How much funding has Synthego raised?

Synthego has raised $460.0M in total funding, most recently a Series E round.

Who are Synthego's investors?

Synthego's investors include Perceptive Advisors, Menlo Ventures, 8VC, SoftBank, Declaration Partners, Laurion Capital Management.

Where is Synthego headquartered?

Synthego is headquartered in Redwood City, California, United States.

What industry is Synthego in?

Synthego operates in Biotech, Genomics, Life Sciences, Hardware.

Synthego

Your Partner in CRISPR & Molecular Diagnostics

Redwood City, United States · Founded 2012 · $460.0M raised

Headquarters: Redwood City, California
Employees: 51–200
Founded: 2012
Business Model: B2B

Website: synthego.com
Total Funding: $460.0M
Last Round: $200.0M Series EFeb 2022
Rounds: 5

About

Synthego is a CRISPR solutions company that provides high-quality reagents, engineered cell lines, and GMP manufacturing services to accelerate life science research and therapeutic development. The company's full-stack genome engineering platform vertically integrates proprietary automation, bioinformatics, and molecular biology to support programs from discovery through clinical trials. Synthego serves thousands of academic and commercial researchers worldwide across gene editing, molecular diagnostics, and cell and gene therapy applications.

Summary

Synthego is a Biotech company based in Redwood City, United States, founded in 2012. It has raised $460.0M in total across 5 rounds, most recently a $200.0M Series E round in Feb 2022. Investors include Perceptive Advisors, Menlo Ventures and 8VC.

LinkedIn X (Twitter)GitHub